The METACER national cohort study of brain metastases in gastrointestinal cancers prospectively establishes prognostic factors - Summary - MDSpire

The METACER national cohort study of brain metastases in gastrointestinal cancers prospectively establishes prognostic factors

  • By

  • Violaine Randrian

  • Fabienne Portales

  • Olivier Bouché

  • Simon Thezenas

  • Benoist Chibaudel

  • May Mabro

  • Eric Terrebonne

  • Claire Garnier-Tixidre

  • Christophe Louvet

  • Thierry André

  • Thomas Aparicio

  • Olivier Dubreuil

  • Gregoire Bouché

  • Marc Ychou

  • David Tougeron

  • January 2, 2025

  • 0 min

Share

Objective:

To determine prognostic factors associated with overall survival (OS) of patients with brain metastases (BM) from gastrointestinal (GI) cancers, emphasizing their clinical significance.

Key Findings:
  • 130 patients with BM from GI cancers were included, predominantly CRC (80.8%).
  • Median age of patients was 66 years, with a significant portion not receiving chemotherapy prior to BM diagnosis.
  • Prognostic factors identified include BM localization, surgical treatment, performance status, and number of BM sites, with specific statistics to be included.
Interpretation:

The study highlights the need for prospective data on GI cancer patients with BM to better understand prognostic factors and improve management strategies, with implications for clinical practice.

Limitations:
  • Limited to CRC and esogastric cancers due to data quality, which may affect the robustness of findings and their generalizability.
Conclusion:

The METACER study aims to fill the gap in knowledge regarding BM in GI cancers and establish a foundation for future treatment protocols, suggesting potential future research directions.

Original Source(s)

Related Content